TISSUE & FFPE COHORT COLLECTIONS
Prostate cancer tissue microarrays & FFPE blocks
Compare prostate cancer arrays by disease context, Gleason information and tissue composition, including selected hormone-refractory and progression collections. For FFPE blocks, share your tissue and study requirements with our team.
THE ARRAYS
Prostate cancer arrays (22)
Collection types in this TMA catalog
Explore the tissue composition and sampling groups represented in these arrays.
Hormone refractory prostate cancers with Gleason scores (TA1843)
- Approx. cores
- 42
- Approx. donors
- 21
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
HRPC with follow up & sequential PSA data (TA3029)
- Approx. cores
- 45
- Approx. donors
- 45
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
HRPC/CRPC tissue microarray with clinical follow-up data (TA4506)
- Approx. cores
- 88
- Approx. donors
- 88
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
IO Multi tumor array 2 of a set of 6 TMAs : Prostate ADC, HRPC/CRPC, Endometrial, Ovarian, Cervical, RCC with histopath data. 1x1mm core each from tumor & invasive edge (TA3125)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
mCRPC TMA with optional follow up data (TA4391)
- Approx. cores
- 50
- Approx. donors
- 50
- Core diameter
- 1 mm
- Clinical follow-up
- Optional follow-up listed
- Marker & molecular data
- Not listed
Metastatic HRPC/CRPC pre and post treatment (not donor matched) with follow up data with PPIB scores (TA4330)
- Approx. cores
- 52
- Approx. donors
- 52
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Not listed
Multi tumor array 1 of a set of 4 TMAs : Breast cancer ER+, Her2+, TNBC, CRC, NSCLC, Prostate ADC with histopath data (TA2995)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
Multi tumor array comprising breast, bladder(uc), ovarian, lung, prostate, melanoma, RCC , head & neck SCC, CRC, pancreatic ADC with histopath data (TA4340)
- Approx. cores
- 120
- Approx. donors
- 120
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Neuroendocrine prostate cancer with follow up data (TA4483)
- Approx. cores
- 38
- Approx. donors
- 19
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Not listed
Normal (non-malignant) breast, colon, lymph node, lung, prostate & breast cancer, CRC, prostate ADC, NSCLC & DLBCL, 2mm (TA2942)
- Approx. cores
- 30
- Approx. donors
- 30
- Core diameter
- 2 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Prostate ADC with histopath data, Gleason scores 6-10, includes hormone refractory (TA1930)
- Approx. cores
- 153
- Approx. donors
- 145
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Prostate ADC: 50 pre- and 50 post- SOC samples/cores, mix of matched and unmatched donor samples for pre/post. Prostate ADC TMA block 1 of 2 (FFPE) (TA4499)
- Approx. cores
- 100
- Approx. donors
- 100
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
Prostate ADC: 50 pre- and 50 post- SOC samples/cores, mix of matched and unmatched donor samples for pre/post. Prostate ADC TMA block 2 of 2 (FFPE) (TA4503)
- Approx. cores
- 100
- Approx. donors
- 100
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Prostate cancer (III/IV) TMA, includes HRPC, Gleason 6-10 with histopath data with PPIB scores (TA3123)
- Approx. cores
- 112
- Approx. donors
- 56
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Prostate cancer incl HRPC (TA1780)
- Approx. cores
- 158
- Approx. donors
- 56
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Prostate cancer incl HRPC (TA1781)
- Approx. cores
- 148
- Approx. donors
- 74
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Prostate cancer primary & matched nodal mets with histopath data (TA3069)
- Approx. cores
- 48
- Approx. donors
- 24
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Prostate cancer progression array with follow up data, includes normal, PIN, Gleason 6-10 (TA2573)
- Approx. cores
- 158
- Approx. donors
- 79
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Not listed
Prostate cancer TMA (TA4362)
- Approx. cores
- 30
- Approx. donors
- 10
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
RNAscope pre-qualified multi tumor array 120 cores total, 1mm core diameter – (same as previous TA4380) (TA4388)
- Approx. cores
- 120
- Approx. donors
- 120
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
RNAscope pre-qualified multi tumor array, 2mm core diameter, TMA1 of a set of 2 TMAs, histopath data (TA3117)
- Approx. cores
- 60
- Approx. donors
- 60
- Core diameter
- 2 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
tumor & invasive edge cores/donor, prostate ADC, HRPC, ovarian, endometrial, RCC, cervical, (TA3109)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
No arrays match these filters
Try another search or clear the filters to see this collection.
Data labels reflect the catalog record. Review each product and datasheet for case-level coverage. Array counts do not indicate stock availability.
FFPE TISSUE BLOCKS
Prostate cancer FFPE blocks for your study
Prostate cohorts with HRPC, PSA, Gleason, treatment or matched-plasma information.
FFPE blocks are requested by inquiry. Our team confirms tissue availability, donor matching and data coverage for your study.
FFPE TISSUE COHORTS
Prostate cancer FFPE cohorts
Select a cohort or patient profile, then share your sample and data requirements with our team.
Cohort #162
HRPC with follow up & sequential PSA data
Cohort #167
Prostate ADC pre- & post-SOC treatment samples (unmatched donors)
Cohort #168
Prostate ADC with histopath data, Gleason scores 6-10
Cohort #185
Prostate ADC with matched double spun plasma
Cohort #170
Prostate cancer (III/IV), includes HRPC, Gleason 6-10 with follow up data
Prostate cancer · Patient profile
Metastatic prostate cancer
Prostate cancer · Patient profile
Metastatic castration-resistant prostate cancer (mCRPC)
Prostate cancer · Patient profile
mCRPC with prior taxane exposure
Prostate cancer · Patient profile
PSMA-positive mCRPC
Prostate cancer · Patient profile
Neuroendocrine prostate carcinoma
SELECTING YOUR ARRAY
Selecting prostate cancer tissue for your study
Compare the represented tissue and the available records before choosing an array. These examples describe individual catalog entries; data coverage is specific to each array.










